NIH-funded research R21 grant

Creating a mouse model to study a genetic cause of glaucoma

Official title: Development and characterization of an inducible model for myocilin POAG

Funded at University of California-Irvine · NIH-10884405 · Data updated 2026-11-12

This study is creating special mice to help us learn more about Primary Open Angle Glaucoma, which can cause blindness, so we can find better treatments for people living with this condition.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California-Irvine
NIH-funded
Lab location1 site (Irvine, United States)
Project startAugust 1, 2023
Project endJuly 31, 2025
Funding year2024
Award (this year)$196,250
NIH project number5R21EY034333-02
Project IDNIH-10884405 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a family history of glaucoma or those diagnosed with Primary Open Angle Glaucoma.

Less likely to help

Patients with other forms of glaucoma or those without a genetic predisposition to POAG may not benefit from this research.

What this research studies

This research focuses on developing a new mouse model to better understand Primary Open Angle Glaucoma (POAG), a leading cause of irreversible blindness. The researchers are using advanced genetic engineering techniques to create mice that express a specific mutant form of the myocilin gene, which is commonly associated with POAG. By studying these mice, the team aims to uncover the mechanisms behind trabecular meshwork dysfunction and neurodegeneration in glaucoma, which could lead to new treatment strategies. Patients may benefit from insights gained through this model that could inform future therapies for glaucoma.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with glaucoma.

How similar studies have gone: Previous research has successfully utilized similar genetic modeling approaches to study other forms of glaucoma, indicating potential for success in this area as well.

Where this research is happening

  • University of California-Irvine
    Irvine, United States
    Active

Researchers

  • Principal investigator: Zode, Gulab — University of California-Irvine
  • Study coordinator: Zode, Gulab

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.